Sign In
Buy CRS
$578.12
-9.65 (-1.64%)
At Close: Jun 23, 2026
DelphX Capital Markets Provides Corporate Update on Structured Income Program and CRS Commercialization
07:42pm, Tuesday, 23'rd Jun 2026
Advancing financing partner alignment for BTC Structured Income Program; in active discussions on a pilot transaction with a major U.S. insurer for Credit Rating Securities Toronto, Ontario and New Yo
Carpenter Technology (CRS) is a Top-Ranked Momentum Stock: Should You Buy?
10:51am, Thursday, 18'th Jun 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Poolbeg's European patent win bolsters partnering case before summer trial data, says Cavendish
06:20am, Tuesday, 16'th Jun 2026
Shares in PPoolbeg Pharma PLC (AIM:POLB) rose 3% to 7.8p on Tuesday, taking their gain for the year to date to around 100%, after the drug developer secured a key European patent. The European Paten
Supporting the Mission: Catholic Relief Services Chooses Adstra as a Fundraising Partner
09:00am, Monday, 15'th Jun 2026
PRINCETON, N.J., June 15, 2026 (GLOBE NEWSWIRE) -- Adstra Nonprofit today announced a strategic partnership with Catholic Relief Services (CRS), one of the world's leading humanitarian organizations.
[url="]Genmab A/S[/url] (Nasdaq: GMAB) today announced new data from two studies evaluating epcoritamab, a T-cell engaging antibody administered subcutaneously
New TALVEYÂ (talquetamab-tgvs) plus DARZALEX FASPROÂ (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combi
Why X Money Could Be Bigger Than PayPal Ever Was
12:00am, Saturday, 13'th Jun 2026
X Money isn't just a payments app. Elon Musk is building a financial super app that could reshape banking and investing.
Organon Wins FDA Nod to Expand TOFIDENCE Use in Severe CRS & COVID-19
10:16am, Friday, 12'th Jun 2026
OGN's TOFIDENCE gains FDA approval for life-threatening CRS and certain hospitalized COVID-19 patients, broadening its critical-care role.
Carpenter Technology Corporation (CRS) Hits Fresh High: Is There Still Room to Run?
10:16am, Wednesday, 10'th Jun 2026
Carpenter (CRS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon receives US FDA approval for expanded indications of TOFIDENCE, a biosimilar to ACTEMRA, in Cytokine Release Syndrome and Pediatric COVID-19.
Why Carpenter Technology (CRS) is a Top Growth Stock for the Long-Term
10:45am, Monday, 08'th Jun 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Carpenter Technology (CRS) Is Up 8.03% in One Week: What You Should Know
01:01pm, Thursday, 04'th Jun 2026
Does Carpenter Technology (CRS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Carpenter (CRS) Upgraded to Buy: Here's Why
01:01pm, Wednesday, 03'rd Jun 2026
Carpenter (CRS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ARKX vs. XAR: Two ETFs Worthy of Consideration
09:44am, Wednesday, 03'rd Jun 2026
One fund leans into disruptive tech, while the other sticks to industry stalwarts-cost, volatility, and sector focus set them apart for investors.
Carpenter Technology Gains on Record Earnings, Profits
07:01am, Wednesday, 03'rd Jun 2026
Institutional inflows push Carpenter Technology Corporation (CRS) shares up 1,894% since 2005.
